DUBLIN--(BUSINESS WIRE)--Dec 5, 2018--The "Chemotherapy-Induced Peripheral Neuropathy (CIPN) - Market Insights, Epidemiology and Market Forecast" drug pipelines has been added to ResearchAndMarkets.com's offering.

The Chemotherapy-Induced Peripheral Neuropathy (CIPN) - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of CIPN in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China.

The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Chemotherapy-Induced Peripheral Neuropathy from 2016 to 2027 segmented by eight major markets. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Chemotherapy-Induced Peripheral Neuropathy Report Insights

Patient PopulationTherapeutic ApproachesPipeline AnalysisMarket Size and TrendsMarket OpportunitiesImpact of upcoming Therapies

Chemotherapy-Induced Peripheral Neuropathy Report Key Strengths

10 Years ForecastG8 CoverageEpidemiology SegmentationKey Cross CompetitionMarket Size by TherapiesDrugs Uptake

Chemotherapy-Induced Peripheral Neuropathy Report Assessment

Pipeline Product ProfilesKey Products and Key PlayersMarket Drivers and Barriers

Key Topics Covered:

1. Key Insights

2. Chemotherapy-Induced Peripheral Neuropathy: Market Overview at a Glance

3. Chemotherapy-Induced Peripheral Neuropathy: Disease Background and Overview

4. Epidemiology and Patient Population

5. Country Wise-Epidemiology of CIPN

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. Unmet Needs

8. Emerging Therapies

9. Chemotherapy Induced Peripheral Neuropathy: G8 Market Analysis

10. United States: Market Outlook

11. EU-5 countries: Market Outlook

12. Japan Market Outlook

13. China Market Outlook

14. Market Drivers

15. Market Barriers

16. Appendix

Companies Mentioned

Achelios TherapeuticsApollo EndosurgeryAsahi Kasei PharmaChromaDexDARA BioSciencesLaboratorios Dr. Esteve S.A.MediciNovaRelief TherapeuticsSolasia/PledPharmaWEX Phamaceuticals

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vrp9d3/global?w=4.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181205005843/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA AFRICA MIDDLE EAST

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES RESEARCH SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/05/2018 04:26 PM/DISC: 12/05/2018 04:26 PM

http://www.businesswire.com/news/home/20181205005843/en

Copyright Business Wire 2018.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.